Earnings calls

INFLUX concall ledger

Every earnings call for INFLUX — management tone, guidance, KPIs and promise tracking, quarter by quarter.

INFLUX · 2 transcripts · Healthcare · latest Q4 FY26

Q4 FY26Published 22 May 2026Call held 22 May 2026

INFLUX Q4 FY26 Earnings Call Transcript & Analysis

Revenue₹80.1 cr+41% YoYEBITDA₹15.2 cr+32% YoYEBITDA Margin20.3%PAT₹10.5 cr+38% YoYPAT Margin14%

Revenue (H2 FY26) ₹80 cr (+41% YoY); EBITDA (H2 FY26) ₹15 cr (+32% YoY); EBITDA Margin (FY26) 20.3%. Revenue from operations grew 41% YoY to INR 80.1 crores in H2 FY26, with full year revenue at INR 146 crores.

Read full transcript & analysis

Q2 FY26Published 12 Nov 2025Call held 12 Nov 2025

INFLUX Q2 FY26 Earnings Call Transcript & Analysis

Revenue from Operations₹66.8 cr+39% YoYEBITDA₹14.7 cr+61% YoYEBITDA Margin22%PAT₹10 cr+78% YoYPAT Margin15%

Revenue from Operations ₹67 cr (+39% YoY); EBITDA ₹15 cr (+61% YoY); EBITDA Margin 22.0%. Revenue from operations grew 39% YoY to INR 66.8 crores in H1 FY26.

Read full transcript & analysis